Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
98.20    -0.80 (-0.81%)
Bid:
98.20
Ask:
98.90
Spread: 0.70 (0.713%)
Market Cap: £597.25m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Directors' Declaration

12 Sep 2014 14:32

BACIT LIMITED - Directors' Declaration

BACIT LIMITED - Directors' Declaration

PR Newswire

London, September 12

BACIT Limited (the "Company") (a closed-ended collective investment company incorporated under the laws of Guernsey with registered number 55514) Dealings by Directors 12 September 2014 Pursuant to Disclosure Rule 3.1, the Company is obliged to notify the market ofDirectors holdings or interests of the Directors or their connected persons inshares of the Company. The Company was notified on 10 September 2014 that, in payment of the Company's2014 dividend, an aggregate of 1,892,450 new ordinary shares were issued on 10September 2014 and the directors of the company received the following sharesat a price equivalent to 113.9 pence per sharein the amounts listed below: Name of director New shares Shareholding following issue of new shares Jeremy Tigue 5,919 343,039 Colin Maltby 1,183 68,607 Jonathan Moulton 17,559 1,017,559 Martin Thomas 2,407 139,527 Peter Hames 1,183 68,607 Company website: www.bacitltd.com Enquiries: Northern Trust International Fund Administration Services (Guernsey) LimitedEmail: rt80@ntrs.comTel: +44 (0)1481 745381
Date   Source Headline
9th Jul 20247:00 amRNSTransaction in Own Shares
8th Jul 202412:35 pmRNSSpur provides update on FLT201
8th Jul 20247:00 amRNSTransaction in Own Shares
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 20247:00 amRNSTransaction in Own Shares
3rd Jul 20245:28 pmRNSDirector Declaration
3rd Jul 20242:22 pmRNSNotice of AGM
3rd Jul 20247:00 amRNSBeacon raises $170 million in a Series B financing
3rd Jul 20247:00 amRNSTransaction in Own Shares
2nd Jul 20247:00 amRNSTransaction in Own Shares
1st Jul 20241:03 pmRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
28th Jun 20247:00 amRNSTransaction in Own Shares
27th Jun 20247:00 amRNSTransaction in Own Shares
26th Jun 202411:37 amRNSDirector/PDMR Shareholding
26th Jun 20247:00 amRNSTransaction in Own Shares
25th Jun 20247:00 amRNSDirector/PDMR Shareholding
25th Jun 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
21st Jun 20247:00 amRNSTransaction in Own Shares
20th Jun 20247:00 amRNSSyncona adds two oncology companies to portfolio
20th Jun 20247:00 amRNSFinal Results
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 202412:05 pmRNSCreation of Spur Therapeutics
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSQuell provides clinical updates on QEL-001
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:18 pmRNSTotal Voting Rights
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20241:51 pmRNSAutolus presents FELIX data at ASCO
31st May 20247:00 amRNSTransaction in Own Shares
30th May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSTransaction in Own Shares
28th May 20247:00 amRNSTransaction in Own Shares
24th May 20247:00 amRNSTransaction in Own Shares
23rd May 20247:00 amRNSNotice of Results
23rd May 20247:00 amRNSTransaction in Own Shares
22nd May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSTransaction in Own Shares
20th May 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.